BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 28197932)

  • 1. Effect of GnRHa ovulation trigger dose on follicular fluid characteristics and granulosa cell gene expression profiles.
    Vuong TNL; Ho MT; Ha TQ; Jensen MB; Andersen CY; Humaidan P
    J Assist Reprod Genet; 2017 Apr; 34(4):471-478. PubMed ID: 28197932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN; Ho MT; Ha TD; Phung HT; Huynh GB; Humaidan P
    Fertil Steril; 2016 Feb; 105(2):356-63. PubMed ID: 26523330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.
    Lee JR; Kim SH; Kim SM; Jee BC; Ku SY; Suh CS; Choi YM; Kim JG; Moon SY
    Fertil Steril; 2008 Apr; 89(4):860-7. PubMed ID: 18249372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard human chorionic gonadotropin versus double trigger for final oocyte maturation results in different granulosa cells gene expressions: a pilot study.
    Haas J; Ophir L; Barzilay E; Machtinger R; Yung Y; Orvieto R; Hourvitz A
    Fertil Steril; 2016 Sep; 106(3):653-659.e1. PubMed ID: 27341989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.
    Fatemi HM; Polyzos NP; van Vaerenbergh I; Bourgain C; Blockeel C; Alsbjerg B; Papanikolaou EG; Humaidan P
    Fertil Steril; 2013 Sep; 100(3):742-7. PubMed ID: 23806846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to ovulation trigger is correlated to late follicular phase progesterone levels: A hypothesis explaining reduced reproductive outcomes caused by increased late follicular progesterone rise.
    Friis Wang N; Skouby SO; Humaidan P; Andersen CY
    Hum Reprod; 2019 May; 34(5):942-948. PubMed ID: 30927415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin.
    Humaidan P; Westergaard LG; Mikkelsen AL; Fukuda M; Yding Andersen C
    Fertil Steril; 2011 May; 95(6):2034-8. PubMed ID: 21377153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GnRH agonist vs. hCG for triggering of ovulation--differential effects on gene expression in human granulosa cells.
    Haas J; Ophir L; Barzilay E; Yerushalmi GM; Yung Y; Kedem A; Maman E; Hourvitz A
    PLoS One; 2014; 9(3):e90359. PubMed ID: 24603682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P; Van Vaerenbergh I; Bourgain C; Alsbjerg B; Blockeel C; Schuit F; Van Lommel L; Devroey P; Fatemi H
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Granulosa cells apoptosis and follicular fluid hormones: comparison of progestin-primed ovarian stimulation versus GnRH antagonist protocols.
    Li X; Zhang X; Cai J; Pang J; Sun P; Chen J; Wang M; Liang X
    Gynecol Endocrinol; 2021 Jul; 37(7):609-613. PubMed ID: 33092415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of gene expression profiles in granulosa and cumulus cells after ovulation induction with either human chorionic gonadotropin or a gonadotropin-releasing hormone agonist trigger.
    Borgbo T; Povlsen BB; Andersen CY; Borup R; Humaidan P; Grøndahl ML
    Fertil Steril; 2013 Oct; 100(4):994-1001. PubMed ID: 23856575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrafollicular content of luteinizing hormone receptor, alpha-inhibin, and aromatase in relation to follicular growth, estrous cycle stage, and oocyte competence for in vitro maturation in the mare.
    Goudet G; Belin F; Bézard J; Gérard N
    Biol Reprod; 1999 May; 60(5):1120-7. PubMed ID: 10208973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist.
    Giampietro F; Sancilio S; Tiboni GM; Rana RA; Di Pietro R
    Fertil Steril; 2006 Feb; 85(2):412-9. PubMed ID: 16595220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of new ovulation-related genes in humans by comparing the transcriptome of granulosa cells before and after ovulation triggering in the same controlled ovarian stimulation cycle.
    Wissing ML; Kristensen SG; Andersen CY; Mikkelsen AL; Høst T; Borup R; Grøndahl ML
    Hum Reprod; 2014 May; 29(5):997-1010. PubMed ID: 24510971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Müllerian hormone is highly expressed and secreted from cumulus granulosa cells of stimulated preovulatory immature and atretic oocytes.
    Kedem-Dickman A; Maman E; Yung Y; Yerushalmi GM; Hemi R; Hanochi M; Dor J; Hourvitz A
    Reprod Biomed Online; 2012 May; 24(5):540-6. PubMed ID: 22421733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone agonist-induced differences in granulosa cell cycle kinetics are associated with alterations in follicular fluid müllerian-inhibiting substance and androgen content.
    Seifer DB; MacLaughlin DT; Penzias AS; Behrman HR; Asmundson L; Donahoe PK; Haning RV; Flynn SD
    J Clin Endocrinol Metab; 1993 Mar; 76(3):711-4. PubMed ID: 8445031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endocrine composition of follicular fluid comparing human chorionic gonadotrophin to a gonadotrophin-releasing hormone agonist for ovulation induction.
    Yding Andersen C; Westergaard LG; Figenschau Y; Bertheussen K; Forsdahl F
    Hum Reprod; 1993 Jun; 8(6):840-3. PubMed ID: 8345072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells.
    Khalaf M; Mittre H; Levallet J; Hanoux V; Denoual C; Herlicoviez M; Bonnamy PJ; Benhaim A
    Reprod Biomed Online; 2010 Jul; 21(1):56-65. PubMed ID: 20457540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting successful induction of oocyte maturation after gonadotropin-releasing hormone agonist (GnRHa) trigger.
    Kummer NE; Feinn RS; Griffin DW; Nulsen JC; Benadiva CA; Engmann LL
    Hum Reprod; 2013 Jan; 28(1):152-9. PubMed ID: 23077235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.